Kaine Applauds Committee Passage of Bipartisan Legislation, Including Bill to Improve Access to Care in Rural Communities

WASHINGTON, D.C. – Today, U.S. Senator Tim Kaine (D-VA), a member of the Senate Health, Education, Labor and Pensions (HELP) Committee, applauded the committee passage of the Improving Care in Rural America Reauthorization Act, bipartisan legislation Kaine introduced to reauthorize programs to improve access to health care in rural communities.

“Everyone – regardless of their ZIP code – deserves access to high-quality medical care. But rural communities across Virginia and the country face unique challenges that can reduce or completely eliminate their access to that care. President Trump’s new law that will rip health care away from more than 15 million Americans and cut funding rural hospitals rely on to keep their doors open will only make those challenges worse. We were able to take a small step forward today in the HELP Committee to provide much-needed funding for health care in rural communities, and I will keep doing all that I can to reverse the dangerous health care policies of this Administration,” said Kaine. “I’m also glad that the HELP Committee passed my bipartisan bill with Senator Banks to improve over-the-counter (OTC) drug safety and modernize the FDA’s review of OTC medications, and my bipartisan bill with Senator Marshall and to help more employees harness a stake in the companies they work for.”

In addition to the Improving Care in Rural America Reauthorization Act, the HELP Committee passed several other pieces of Kaine-led legislation. The committee passed a bipartisan bill to reauthorize the Food and Drug Administration’s (FDA) Over-the-Counter Monograph User Fee Program (OMUFA), which modernizes the FDA’s review of OTC medications with support from drug manufacturer user fees, until fiscal year (FY) 2030. Included in that text, the committee also passed the Kaine-led OTC Monograph Drug User Fee Transparency Act, mandating that the FDA annually provide information about OTC drug safety, adverse effects, the speed with which the FDA processes OTC monograph order requests, and other matters related to the safe and timely regulation of over-the-counter drugs. The legislation also requires that the FDA provide the Senate HELP Committee and the House Committee on Energy and Commerce with a report after two years on the status of the OTC drug supply chain. The committee also passed the Retire through Ownership Act, led by Kaine and Senator Roger Marshall, M.D. (R-KS), which provides crucial guidance to facilitate the formation and continued operation of employee stock ownership plans (ESOPs). ESOPs allow all workers to directly share in the profits they help their company earn, leading to higher wages and more wealth-building.

###